Publications en collaboration avec des chercheurs de Instituto Ramón y Cajal de Investigación Sanitaria (60)

2024

  1. (, 10.2139/ssrn.4579870)

    Frontiers in Immunology

  2. Chlamydia Trachomatis Prevalence in Asymptomatic Women in Madrid: Study Findings and Their Association with Risk Factors and Mental Health

    Biomedicines, Vol. 12, Núm. 9

  3. Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV

    The Journal of infectious diseases, Vol. 230, Núm. 2, pp. 421-425

  4. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  2. Contribution of Low CD4 Cell Counts and High Human Immunodeficiency Virus (HIV) Viral Load to the Efficacy of Preferred First-Line Antiretroviral Regimens for Treating HIV Infection: A Systematic Review and Meta-Analysis

    Clinical Infectious Diseases, Vol. 76, Núm. 11, pp. 2027-2037

  3. Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 3, pp. 823-827

  4. From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications

    Pathogens, Vol. 12, Núm. 7

  5. HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

    Frontiers in Public Health, Vol. 11

  6. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases

  7. Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection

    Journal of Fungi, Vol. 9, Núm. 2

  8. Is It Time for Treatment as Prevention of Chronic Hepatitis B?

    Pathogens, Vol. 12, Núm. 9

  9. Prevalence, characteristics, and associated risk factors of drug consumption and chemsex use among individuals attending an STI clinic (EpITs STUDY)

    Frontiers in Public Health, Vol. 11

  10. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2022

  1. Actions and attitudes on the immunized patients against SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 7-15

  2. An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population

    Microbiology spectrum, Vol. 10, Núm. 2, pp. e0228621

  3. COVID in Pediatric Age: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343

  4. COVID-19: Some unresolved issues

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 421-434

  5. Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019

    HIV Medicine, Vol. 23, Núm. 7, pp. 705-716

  6. Global strategy in the treatment of HIV infection in 2022

    Revista Espanola de Quimioterapia, Vol. 35, pp. 34-36